Early Response Monitoring with 18F-FDG PET and Cetuximab-F(ab′)2-SPECT After Radiotherapy of Human Head and Neck Squamous Cell Carcinomas in a Mouse Model

@article{Dijk2014EarlyRM,
  title={Early Response Monitoring with 18F-FDG PET and Cetuximab-F(ab′)2-SPECT After Radiotherapy of Human Head and Neck Squamous Cell Carcinomas in a Mouse Model},
  author={Laura K van Dijk and O. Boerman and G. Franssen and J. Lok and J. Kaanders and J. Bussink},
  journal={The Journal of Nuclear Medicine},
  year={2014},
  volume={55},
  pages={1665 - 1670}
}
Only a subset of patients with head and neck squamous cell carcinomas (HNSCCs) benefit from radiotherapy and concurrent epidermal growth factor receptor (EGFR) inhibitor therapy with cetuximab, indicating the need for patient selection. The aim of this study was to visualize the change in systemically accessible EGFR with 111In-cetuximab-F(ab′)2 SPECT before and after radiotherapy, while simultaneously evaluating 18F-FDG PET uptake. Methods: Mice with HNSCC xenografts, cetuximab-sensitive… Expand
11 Citations
PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology
Epidermal growth factor receptor imaging in human head and neck cancer xenografts
Anti-EGFR Therapy: Strategies in Head and Neck Squamous Cell Carcinoma.
...
1
2
...

References

SHOWING 1-10 OF 40 REFERENCES
111In-cetuximab-F(ab')2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts.
  • Laura K van Dijk, B. Hoeben, +4 authors J. Bussink
  • Medicine, Materials Science
  • Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 2013
Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer.
  • D. Zips, K. Zöphel, +7 authors M. Baumann
  • Medicine
  • Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 2012
Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential.
  • L. Koi, R. Bergmann, +6 authors M. Baumann
  • Medicine
  • Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 2014
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?
PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models
Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report.
...
1
2
3
4
...